Tris Pharma
John David is a seasoned business analyst with extensive experience in the financial services industry, currently serving as a Senior Business Analyst at Tris Pharma since January 2017, specializing in ERP systems like JD Edwards. Prior roles include Senior Business Analyst at Citi, where contributions were made to the Fund Services Reporting system, and Project Manager/Business Analyst in Hedge Fund Services. John's career also features significant positions at Brown Brothers Harriman as Assistant Vice President, managing UI development teams, and at Morgan Stanley, where responsibilities included project lifecycle management and database administration. Additional consulting experience was gained at CapitalStar Systems and Paragon, with early roles as a Senior Programmer Analyst at PaperDirect and internships at notable firms like Prudential and Johnson & Johnson. John holds a Bachelor of Science in Computer Science from New Jersey City University.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.